Fendiline

Fendiline
Clinical data
ATC code	C08EA01 (WHO) ;
Identifiers
	IUPAC name 3,3-diphenyl-N-(1-phenylethyl)propan-1-amine;
CAS Number	13042-18-7 ;
PubChem CID	3336;
DrugBank	DB08980 ;
ChemSpider	3219 ;
UNII	S253D559A8;
KEGG	D07185 ;
ChEMBL	ChEMBL254832 ;
CompTox Dashboard (EPA)	DTXSID5048473 ;
ECHA InfoCard	100.032.635
Chemical and physical data
Formula	C23H25N
Molar mass	315.460 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(NCCC(c1ccccc1)c2ccccc2)c3ccccc3;
	InChI InChI=1S/C23H25N/c1-19(20-11-5-2-6-12-20)24-18-17-23(21-13-7-3-8-14-21)22-15-9-4-10-16-22/h2-16,19,23-24H,17-18H2,1H3 ; Key:NMKSAYKQLCHXDK-UHFFFAOYSA-N ;
	(what is this?) (verify)

Fendiline is a nonselective calcium channel blocker.^[1]^[2]

References

^ Scultéty S, Tamáskovits E (1991). "Effect of Ca2+ antagonists on isolated rabbit detrusor muscle". Acta Physiologica Hungarica. 77 (3–4): 269–78. PMID 1755331.
^ "Fendiline - an overview | ScienceDirect Topics".

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.